Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation

scientific article published on 27 October 2020

Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2020NatCo..11.5413H
P356DOI10.1038/S41467-020-19231-9
P698PubMed publication ID33110068

P50authorAndrew McGuireQ56454340
Nicholas HurlburtQ57468178
Mehul S. SutharQ90167763
Marie PanceraQ101038499
Venkata Viswanadh EdaraQ101561612
P2093author name stringJunli Feng
Leonidas Stamatatos
Andrew B Stuart
Emilie Seydoux
Yu-Hsin Wan
P2860cites workXDSQ27860472
Coot: model-building tools for molecular graphicsQ27860505
Phasercrystallographic softwareQ27860930
Recent developments in the PHENIX software for automated crystallographic structure determinationQ29620754
Structural diversity in a human antibody germline libraryQ36025752
GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins.Q42825895
Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virusQ57794103
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus FusionQ84315378
An interactive web-based dashboard to track COVID-19 in real timeQ87456354
Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2Q87726414
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike GlycoproteinQ87973551
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorQ88292103
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformationQ89108866
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronavirusesQ89866691
SARS-CoV-2 is an appropriate name for the new coronavirusQ90164541
Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inactionQ90280296
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoVQ90713511
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2Q91807337
An Infectious cDNA Clone of SARS-CoV-2Q91914454
A human monoclonal antibody blocking SARS-CoV-2 infectionQ94440473
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization AssaysQ94567274
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2Q94670272
A human neutralizing antibody targets the receptor binding site of SARS-CoV-2Q95851276
Human neutralizing antibodies elicited by SARS-CoV-2 infectionQ95851279
Broad neutralization of SARS-related viruses by human monoclonal antibodiesQ96429124
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic MutationQ96607975
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of AntibodiesQ97519832
Structural basis of a shared antibody response to SARS-CoV-2Q97526726
P433issue1
P921main subjectSARS-CoV-2Q82069695
P304page(s)5413
P577publication date2020-10-27
P1433published inNature CommunicationsQ573880
P1476titleStructural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
P478volume11

Reverse relations

cites work (P2860)
Q107980765SARS-CoV-2 Unrevealed: Ultrastructural and Nanomechanical Analysis
Q99707961Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy

Search more.